New technology
USA for widely available equipment to prevent migraine
On March 11, the US Food and Drug Administration (FDA) approved the sale of STX-Med for the treatment of STIs by the STX-Med company. of Belgium.
Browse ScienceInfo articles and explainers related to Migraine Prevention.
1 published item.
On March 11, the US Food and Drug Administration (FDA) approved the sale of STX-Med for the treatment of STIs by the STX-Med company. of Belgium.